Lab Directors Should Follow cfDNA Testing Progress in Ongoing Study
AMP Annual Meeting attendees showed strong interest in the blood test
AMP Annual Meeting attendees showed strong interest in the blood test
From - Diagnostic Testing & Emerging Technologies
Whole-genome sequencing (WGS) identifies additional genetic causes of hypertrophic cardiomyopathy (HCM) beyond those identified through targeted…
From - Diagnostic Testing & Emerging Technologies
Next-generation sequencing improves definitive diagnoses for children with drug-resistant epilepsy, according to a pilot study published online…
From - Diagnostic Testing & Emerging Technologies
As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by…
From - Diagnostic Testing & Emerging Technologies
Expanded next-generation sequencing-based carrier screening improves detection of rare and novel pathogenic variants even in…
From - Diagnostic Testing & Emerging Technologies
A genetic risk score (GRS) may identify patients at highest risk for developing atrial fibrillation (AF), according to a study published…
From - Diagnostic Testing & Emerging Technologies
The vast majority of sudden infant death syndrome (SIDS) cases are not the result of genetic heart diseases (GHDs) or a single genetic cause…
From - Diagnostic Testing & Emerging Technologies
Researchers have developed the first multiplex array for diagnosis of tickborne diseases, according to a study published online…